Clinical Trials Search Results

  • Resize font
  • Print
  • Email
  • Facebook
  • Twitter
  • Google+
  • Pinterest

Initial search results include only NCI-sponsored clinical trials. To search all trials, click the "REFINE SEARCH" button, scroll down to the Trial ID/Sponsor section and select the "All" check box in the Sponsor of Trial section.

View Content for:
Display:
?
Drug:  rubitecan
Find trials that include:  Any drugs shown
Trial Status:  Closed
Results 1-17 of 17 for your search:
Start Over
Phase II Study of Oral Nitrocamptothecin in Advanced Pancreatic Adenocarcinoma (Summary Last Modified 04/2000)
Phase: Phase II
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: Other
Protocol IDs: SFFCR-IND-45-952, NCI-V96-0998
Nitrocamptothecin in Treating Patients With Stage IV Prostate Cancer That Has Not Responded to Hormone Therapy
Phase: Phase II
Type: Treatment
Status: Completed
Age: Not specified
Sponsor: NCI, Other
Protocol IDs: CDR0000067827, CLB-99901, GUMC-00192, CALGB-99901, NCT00005820
Nitrocamptothecin in Treating Patients With Glioblastoma Multiforme
Phase: Phase II
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: Other
Protocol IDs: EORTC-16996G, NCT00005826
Nitrocamptothecin in Treating Patients With Metastatic Cancer of the Urinary Tract
Phase: Phase II
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: Other
Protocol IDs: EORTC-16996U, NCT00006026
Nitrocamptothecin in Treating Patients With Advanced Small Cell Lung Cancer
Phase: Phase II
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: Other
Protocol IDs: EORTC-16996SL, NCT00006082
Nitrocamptothecin in Treating Patients With Advanced Ovarian Cancer
Phase: Phase II
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: Other
Protocol IDs: EORTC-16996O, NCT00006230
Combination Therapy With Oral 9-Nitrocamptothecin & Oral Etoposide
Phase: Phase I
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: MCC-12177, NCI-G00-1821, NCT00006047
Study of Rubitecan in Cancer Patients With Renal or Hepatic Dysfunction
Phase: Phase I
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: RFS 2000-40, SGI-RUB-040, RFS 2000-040, NCT00113113
Start Over